Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

NCT00087048 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Lung Cancer

Interventions

DRUG: topotecan hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]